Location History:
- Stanford, CA (US) (2001 - 2004)
- Seattle, WA (US) (2008 - 2010)
Company Filing History:
Years Active: 2001-2010
Title: The Innovations of Peter Small
Introduction
Peter Small is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of mycobacterial research, holding a total of 4 patents. His work focuses on identifying genetic deletions in mycobacteria isolates, which has important implications for tuberculosis diagnosis and vaccine development.
Latest Patents
Peter Small's latest patents involve the identification of specific genetic deletions in mycobacteria isolates. These deletions serve as markers to distinguish between pathogenic and avirulent strains. They also help in identifying variations in the genome sequence between different isolates. Notably, deletions specific to vaccine strains of BCG are useful in determining whether a positive tuberculin skin test indicates actual tuberculosis infection. The deleted sequences may be reintroduced into BCG to enhance vaccination efficacy. Alternatively, the genetic sequences corresponding to these deletions can be removed to attenuate pathogenic bacteria.
Career Highlights
Peter Small is affiliated with Leland Stanford Junior University, where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Some of his notable coworkers include Marcel Behr and Gary K Schoolnik, who have collaborated with him on various research projects.
Conclusion
Peter Small's contributions to mycobacterial research and his innovative patents play a crucial role in improving tuberculosis diagnostics and vaccine development. His work continues to impact the field significantly.